首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Challenges to rational prescribing and use of essential medicines in India
【24h】

Challenges to rational prescribing and use of essential medicines in India

机译:印度合理处方和使用基本药物的挑战

获取原文
           

摘要

The concept of essential medicines was introduced in 1977 with the publication of the World Health Organization's (WHO) Model List of Essential Medicines. These medicines are intended to satisfy the priority health care needs of the population. They are selected with regard to public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and at a price the individual and the community can afford. The WHO advises countries to adapt the essential medicines list according to their priority health care needs. The model list of WHO serves as a guide for the development of a national list of essential medicines (NLEM). An essential medicines list can serve as a model for procurement, local licensing and manufacturing, and the rational use of good-quality medicines, especially within the public sector. It also helps in allocating limited resources effectively and in a cost-effective manner.
机译:基本药物的概念在1977年随着世界卫生组织(WHO)基本药物标准清单的发布而引入。这些药物旨在满足人们的优先医疗保健需求。选择它们时要考虑到公共卫生的相关性,功效和安全性的证据以及比较的成本效益。基本药物旨在在正常运行的卫生系统范围内随时以适当的量,适当的剂型,有保证的质量和个人和社区负担得起的价格提供。世卫组织建议各国根据其优先卫生保健需求调整基本药物清单。世卫组织的示范清单可作为制定国家基本药物清单(NLEM)的指南。基本药物清单可以作为采购,本地许可和制造以及合理使用优质药物的模型,尤其是在公共部门。它还有助于以经济高效的方式有效分配有限的资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号